ArticleCancer immunology, immunotherapy : CII2022

Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma.

Li Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.